首页 > 最新文献

Chinese Neurosurgical Journal最新文献

英文 中文
The efficacy of surgery over stereotactic radiosurgery in the management of tumor-related trigeminal neuralgia. 在治疗与肿瘤相关的三叉神经痛时,手术比立体定向放射手术更有效。
Q2 Medicine Pub Date : 2024-10-01 DOI: 10.1186/s41016-024-00379-y
Alexander Abouharb, Hasithe Rathnayake, Sachit Mehta

Tumor-related trigeminal neuralgia (TN) is a deeply debilitating condition that severely impacts patient quality of life. Two principal treatment methods in use are open surgical resection of the causative tumor or the use of stereotactic radiosurgery (SRS). In this letter, we aim to evaluate the use of both treatment methods and highlight that in patients with commensurate anatomy, open surgical resection continues to provide greater rates of symptomatic relief, lower rates of recurrence, and complication compared to stereotactic radiosurgery.

与肿瘤相关的三叉神经痛(TN)是一种让人极度衰弱的疾病,严重影响患者的生活质量。目前使用的两种主要治疗方法是开放性手术切除致病肿瘤或使用立体定向放射手术(SRS)。在这封信中,我们旨在对这两种治疗方法的使用情况进行评估,并着重指出,与立体定向放射手术相比,在具有相应解剖结构的患者中,开放性手术切除仍能提供更高的症状缓解率、更低的复发率和并发症发生率。
{"title":"The efficacy of surgery over stereotactic radiosurgery in the management of tumor-related trigeminal neuralgia.","authors":"Alexander Abouharb, Hasithe Rathnayake, Sachit Mehta","doi":"10.1186/s41016-024-00379-y","DOIUrl":"10.1186/s41016-024-00379-y","url":null,"abstract":"<p><p>Tumor-related trigeminal neuralgia (TN) is a deeply debilitating condition that severely impacts patient quality of life. Two principal treatment methods in use are open surgical resection of the causative tumor or the use of stereotactic radiosurgery (SRS). In this letter, we aim to evaluate the use of both treatment methods and highlight that in patients with commensurate anatomy, open surgical resection continues to provide greater rates of symptomatic relief, lower rates of recurrence, and complication compared to stereotactic radiosurgery.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic plain abdominal film provides simple and effective diagnosis of delayed shunt insufficiency caused by abdominal adhesions after VP shunt. 动态腹部平片可简单有效地诊断 VP 分流术后腹部粘连导致的延迟性分流不全。
Q2 Medicine Pub Date : 2024-09-03 DOI: 10.1186/s41016-024-00378-z
Zhiqiang Liu, Jintao Chen, Chaoqun Weng, Bei Liu, Zhixiong Lin

Background: Many complications may occur after placement of the ventriculoperitoneal shunt (VP shunt) for hydrocephalus, and delayed shunt insufficiency (DSI) is among the most common. It is often caused by abdominal adhesions, which increases the difficulty of diagnosis. This study aimed to explore the clinical value of dynamic plain abdominal radiography (DPAR) as a simple diagnostic method for patients with DSI due to terminal adhesion of the peritoneal shunt after VP surgery.

Methods: A total of 30 patients with high suspicion of DSI due to abdominal adhesions after VP surgery were included. DPAR was used for prospective assessment. The interval between the first and second PAR was 4-6 h before surgery. If two plain abdominal radiography at different times indicated that the end of the shunt tube in the abdominal segment was fixed, it was diagnosed as DSI due to adhesion of the shunt tube at the abdominal end. The peritoneal end of the shunt tube was surgically repositioned. Postoperative DPAR was repeated to evaluate the distance of the shunt outlet within the abdominal segment.

Results: All cases showed clinical symptoms or imaging findings of shunt insufficiency. The diagnostic accuracy of DPAR was 96.67% (29/30). The end of the shunt tube in the abdominal segment of the preoperative group was fixed with abdominal plain film twice with a mean difference of 1.74 ± 1.18 cm. The mean postoperative change in the position of the end of the shunt tube in the abdominal section was 9.36 ± 2.64 cm, showing a significant difference compared with the preoperative group (P < 0.001). The mean postoperative EVANs index (0.37 ± 0.08) was significantly lower than the preoperative (0.42 ± 0.08) (P = 0.007), Glasgow coma scale score (12.8 ± 2.69) was higher than the mean preoperative score (11.36 ± 2.43) (P = 0.013).

Conclusion: DPAR is a simple and effective method for the diagnosis of shunt insufficiency caused by delayed abdominal end adhesion after VP shunt.

背景:放置脑室腹腔分流术(VP 分流术)治疗脑积水后可能会出现许多并发症,而迟发性分流不全(DSI)是最常见的并发症之一。它通常由腹腔粘连引起,这增加了诊断的难度。本研究旨在探讨腹部动态平片(DPAR)作为一种简便的诊断方法对VP手术后腹腔分流管末端粘连所致DSI患者的临床价值:方法:共纳入 30 例因 VP 手术后腹腔粘连而高度怀疑 DSI 的患者。采用 DPAR 进行前瞻性评估。第一次和第二次PAR之间的间隔时间为术前4-6小时。如果两次不同时间的腹部平片显示分流管腹部末端固定,则诊断为分流管腹部末端粘连导致的 DSI。通过手术将分流管的腹膜端重新定位。术后再次进行DPAR检查,以评估分流管出口在腹腔内的距离:结果:所有病例均出现分流管功能不全的临床症状或影像学检查结果。DPAR的诊断准确率为96.67%(29/30)。术前组腹部分流管末端与腹部平片两次固定的平均差值为 1.74 ± 1.18 厘米。术后腹部分流管末端位置变化的平均值为(9.36±2.64)厘米,与术前组相比差异显著(P 结论:DPAR 是一种简便、有效的分流管位置测量方法:DPAR 是诊断 VP 分流术后腹腔末端延迟粘连导致的分流管功能不全的一种简单有效的方法。
{"title":"Dynamic plain abdominal film provides simple and effective diagnosis of delayed shunt insufficiency caused by abdominal adhesions after VP shunt.","authors":"Zhiqiang Liu, Jintao Chen, Chaoqun Weng, Bei Liu, Zhixiong Lin","doi":"10.1186/s41016-024-00378-z","DOIUrl":"10.1186/s41016-024-00378-z","url":null,"abstract":"<p><strong>Background: </strong>Many complications may occur after placement of the ventriculoperitoneal shunt (VP shunt) for hydrocephalus, and delayed shunt insufficiency (DSI) is among the most common. It is often caused by abdominal adhesions, which increases the difficulty of diagnosis. This study aimed to explore the clinical value of dynamic plain abdominal radiography (DPAR) as a simple diagnostic method for patients with DSI due to terminal adhesion of the peritoneal shunt after VP surgery.</p><p><strong>Methods: </strong>A total of 30 patients with high suspicion of DSI due to abdominal adhesions after VP surgery were included. DPAR was used for prospective assessment. The interval between the first and second PAR was 4-6 h before surgery. If two plain abdominal radiography at different times indicated that the end of the shunt tube in the abdominal segment was fixed, it was diagnosed as DSI due to adhesion of the shunt tube at the abdominal end. The peritoneal end of the shunt tube was surgically repositioned. Postoperative DPAR was repeated to evaluate the distance of the shunt outlet within the abdominal segment.</p><p><strong>Results: </strong>All cases showed clinical symptoms or imaging findings of shunt insufficiency. The diagnostic accuracy of DPAR was 96.67% (29/30). The end of the shunt tube in the abdominal segment of the preoperative group was fixed with abdominal plain film twice with a mean difference of 1.74 ± 1.18 cm. The mean postoperative change in the position of the end of the shunt tube in the abdominal section was 9.36 ± 2.64 cm, showing a significant difference compared with the preoperative group (P < 0.001). The mean postoperative EVANs index (0.37 ± 0.08) was significantly lower than the preoperative (0.42 ± 0.08) (P = 0.007), Glasgow coma scale score (12.8 ± 2.69) was higher than the mean preoperative score (11.36 ± 2.43) (P = 0.013).</p><p><strong>Conclusion: </strong>DPAR is a simple and effective method for the diagnosis of shunt insufficiency caused by delayed abdominal end adhesion after VP shunt.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"26"},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with radiographic progression and neurologic decline in patients with isolated traumatic subarachnoid hemorrhage. 孤立性外伤性蛛网膜下腔出血患者放射学进展和神经功能衰退的相关因素。
Q2 Medicine Pub Date : 2024-08-06 DOI: 10.1186/s41016-024-00377-0
Kaushik Ravipati, Inamullah Khan, Wesley Chen, Ravi Nunna, Aaron Voshage, Sasidhar Karuparti, Ismail Ziu, Michael Ortiz

Background: Complicated mild traumatic brain injury (cmTBI) is a common neurosurgical disorder that consumes a significant amount of healthcare resources without a clearly established benefit. Best practices for the management of cmTBI regarding triage, hospital admission, and the necessity for repeat imaging are controversial. Our objective is to describe the rate of radiographic progression and neurologic decline for isolated traumatic subarachnoid hemorrhage (itSAH) patients admitted to the hospital. We hypothesized that only a minority of itSAH patients suffer radiographic progression and that radiographic progression is not necessarily associated with neurologic decline.

Methods: Database queries and direct patient chart reviews were used to gather patient data. T-tests and Fisher's exact tests were performed.

Results: A total of 340 patients with cmTBI associated with itSAH were included for analysis. The radiographic progression rate was 5.6%. There was no statistically significant association between age, gender, GCS at presentation, anticoagulation status, and risk of radiographic progression. However, subgroup analysis on anticoagulated patients did show those on warfarin had a statistically significant risk of radiographic progression (p = 0.003). No patient developed neurologic decline, irrespective of whether they developed radiographic progression.

Conclusion: Secondary triaging, hospital admission, ICU stay, and repeat HCT might not be necessary for awake, GCS 13-15 patients with itSAH without any other significant injuries. In the case of anticoagulant use, but not necessarily antiplatelet use, the medication should be reversed, and admission should be considered.

背景:并发性轻微脑外伤(cmTBI)是一种常见的神经外科疾病,它消耗了大量的医疗资源,却没有明显的疗效。关于 cmTBI 的分诊、入院和重复成像必要性的最佳管理方法尚存在争议。我们的目的是描述入院的孤立性创伤性蛛网膜下腔出血(itSAH)患者的影像学进展率和神经功能衰退情况。我们假设,只有少数蛛网膜下腔出血患者会出现影像学进展,而且影像学进展与神经功能衰退没有必然联系:方法:采用数据库查询和直接查看病历的方法收集患者数据。方法:采用数据库查询和直接查阅病历的方法收集患者数据,并进行T检验和费雪精确检验:结果:共纳入340例cmTBI伴itSAH患者进行分析。放射学进展率为 5.6%。年龄、性别、发病时的 GCS、抗凝状态与放射学进展风险之间没有统计学意义上的关联。不过,对抗凝药患者进行的亚组分析表明,服用华法林的患者出现放射学进展的风险具有统计学意义(P = 0.003)。无论是否出现放射学进展,没有患者出现神经功能衰退:结论:对于神志清醒、GCS 13-15 分、无其他明显损伤的 itSAH 患者,可能不需要二次分诊、入院、入住重症监护室和重复 HCT。如果使用了抗凝剂,但不一定使用了抗血小板药物,则应停药并考虑入院。
{"title":"Factors associated with radiographic progression and neurologic decline in patients with isolated traumatic subarachnoid hemorrhage.","authors":"Kaushik Ravipati, Inamullah Khan, Wesley Chen, Ravi Nunna, Aaron Voshage, Sasidhar Karuparti, Ismail Ziu, Michael Ortiz","doi":"10.1186/s41016-024-00377-0","DOIUrl":"10.1186/s41016-024-00377-0","url":null,"abstract":"<p><strong>Background: </strong>Complicated mild traumatic brain injury (cmTBI) is a common neurosurgical disorder that consumes a significant amount of healthcare resources without a clearly established benefit. Best practices for the management of cmTBI regarding triage, hospital admission, and the necessity for repeat imaging are controversial. Our objective is to describe the rate of radiographic progression and neurologic decline for isolated traumatic subarachnoid hemorrhage (itSAH) patients admitted to the hospital. We hypothesized that only a minority of itSAH patients suffer radiographic progression and that radiographic progression is not necessarily associated with neurologic decline.</p><p><strong>Methods: </strong>Database queries and direct patient chart reviews were used to gather patient data. T-tests and Fisher's exact tests were performed.</p><p><strong>Results: </strong>A total of 340 patients with cmTBI associated with itSAH were included for analysis. The radiographic progression rate was 5.6%. There was no statistically significant association between age, gender, GCS at presentation, anticoagulation status, and risk of radiographic progression. However, subgroup analysis on anticoagulated patients did show those on warfarin had a statistically significant risk of radiographic progression (p = 0.003). No patient developed neurologic decline, irrespective of whether they developed radiographic progression.</p><p><strong>Conclusion: </strong>Secondary triaging, hospital admission, ICU stay, and repeat HCT might not be necessary for awake, GCS 13-15 patients with itSAH without any other significant injuries. In the case of anticoagulant use, but not necessarily antiplatelet use, the medication should be reversed, and admission should be considered.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"25"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11302199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Planning a sustainable neurosurgery mentorship program in a war-torn country: experience from Iraq. 在战乱国家规划可持续的神经外科导师计划:伊拉克的经验。
Q2 Medicine Pub Date : 2024-08-02 DOI: 10.1186/s41016-024-00376-1
Teeba A Al-Ageely, Mustafa Ismail, Zinah A Alaraji, Jaafar Abdulwahid, Fatima Ayad, Huda Jaafar, Awfa Aktham, Hayder R Salih, Samer Hoz

The importance of mentorships in medical education and neurosurgery is highly attributed to the support and encouragement of the advances and learning opportunities for medical students and junior neurosurgeons. Planning a mentorship program according to the target audience offers to satisfy different interests and enhance education. One of the main issues with most of the already implemented programs is the sustainability and inability to maintain continuous cycles of mentorship, which have a negative impact and have led to an interrupted pattern of learning which eventually leads to a decline in the engagement of participants and loss of interest. This problem is most pronounced in war-torn countries, with Iraq as an example, where external circumstances lead to an arrest in the educational process and a depletion of the resources useful for such programs and training courses. This paper aims to address the main pathways essential in planning a sustainable mentorship program in a war-torn country by highlighting our experience in maintaining an ongoing mentorship with nine consecutive courses over the last 6 years in Iraq.

导师制在医学教育和神经外科中的重要性,主要体现在支持和鼓励医学生和初级神经外科医生的进步和学习机会上。根据目标受众规划导师计划可满足不同的兴趣并加强教育。大多数已实施项目的主要问题之一是可持续性问题,无法保持导师制的持续循环,从而产生负面影响,导致学习模式中断,最终导致参与者参与度下降,失去兴趣。这一问题在饱受战争蹂躏的国家最为突出,伊拉克就是一个例子,外部环境导致教育进程停滞,此类计划和培训课程的有用资源枯竭。本文旨在阐述在战乱国家规划可持续导师计划的主要途径,重点介绍我们在过去 6 年中在伊拉克连续举办 9 期课程、维持持续导师计划的经验。
{"title":"Planning a sustainable neurosurgery mentorship program in a war-torn country: experience from Iraq.","authors":"Teeba A Al-Ageely, Mustafa Ismail, Zinah A Alaraji, Jaafar Abdulwahid, Fatima Ayad, Huda Jaafar, Awfa Aktham, Hayder R Salih, Samer Hoz","doi":"10.1186/s41016-024-00376-1","DOIUrl":"10.1186/s41016-024-00376-1","url":null,"abstract":"<p><p>The importance of mentorships in medical education and neurosurgery is highly attributed to the support and encouragement of the advances and learning opportunities for medical students and junior neurosurgeons. Planning a mentorship program according to the target audience offers to satisfy different interests and enhance education. One of the main issues with most of the already implemented programs is the sustainability and inability to maintain continuous cycles of mentorship, which have a negative impact and have led to an interrupted pattern of learning which eventually leads to a decline in the engagement of participants and loss of interest. This problem is most pronounced in war-torn countries, with Iraq as an example, where external circumstances lead to an arrest in the educational process and a depletion of the resources useful for such programs and training courses. This paper aims to address the main pathways essential in planning a sustainable mentorship program in a war-torn country by highlighting our experience in maintaining an ongoing mentorship with nine consecutive courses over the last 6 years in Iraq.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"23"},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11295299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stellate ganglion block: what else is necessary to include in the treatment of subarachnoid hemorrhage patients? 星状神经节阻滞:在治疗蛛网膜下腔出血患者时还需要做些什么?
Q2 Medicine Pub Date : 2024-08-01 DOI: 10.1186/s41016-024-00374-3
Leonardo C Welling, Nicollas Nunes Rabelo, Mateus Gonçalves de Sena Barbosa, Beatriz Rodrigues Messias, Carolina Guimarães Pinto, Eberval Gadelha Figueiredo

Cerebral vasospasm is determined as a temporary narrowing of cerebral arteries a few days after an aneurysmal subarachnoid hemorrhage. The onset of this vascular event usually evolves with new neurological deficits or progression of ischemic areas. The success of interventions to treat or revert this condition is not satisfying. In addition to cerebral vasospasm, early brain injury plays an important role as a contributor to subarachnoid hemorrhage's mortality. In this sense, stellate ganglion block appears as an alternative to reduce sympathetic system's activation, one of the main pathophysiological mechanisms involved in brain injury. Over the past few years, there is growing evidence that stellate ganglion block can contribute to decline patient morbidity from subarachnoid hemorrhage. Is it time to include this procedure as a standard treatment after aneurysm rupture?

脑血管痉挛被认为是动脉瘤性蛛网膜下腔出血后几天内脑动脉的暂时性狭窄。这种血管事件的发生通常伴随着新的神经功能缺损或缺血区域的进展。治疗或逆转这种情况的干预措施的成功率并不令人满意。除脑血管痉挛外,早期脑损伤也是导致蛛网膜下腔出血死亡的重要因素。从这个意义上讲,星状神经节阻滞似乎是减少交感神经系统激活的一种替代方法,而交感神经系统激活是脑损伤的主要病理生理机制之一。过去几年中,越来越多的证据表明,星状神经节阻滞术有助于降低蛛网膜下腔出血患者的发病率。现在是将这种手术作为动脉瘤破裂后的标准治疗方法的时候了吗?
{"title":"Stellate ganglion block: what else is necessary to include in the treatment of subarachnoid hemorrhage patients?","authors":"Leonardo C Welling, Nicollas Nunes Rabelo, Mateus Gonçalves de Sena Barbosa, Beatriz Rodrigues Messias, Carolina Guimarães Pinto, Eberval Gadelha Figueiredo","doi":"10.1186/s41016-024-00374-3","DOIUrl":"10.1186/s41016-024-00374-3","url":null,"abstract":"<p><p>Cerebral vasospasm is determined as a temporary narrowing of cerebral arteries a few days after an aneurysmal subarachnoid hemorrhage. The onset of this vascular event usually evolves with new neurological deficits or progression of ischemic areas. The success of interventions to treat or revert this condition is not satisfying. In addition to cerebral vasospasm, early brain injury plays an important role as a contributor to subarachnoid hemorrhage's mortality. In this sense, stellate ganglion block appears as an alternative to reduce sympathetic system's activation, one of the main pathophysiological mechanisms involved in brain injury. Over the past few years, there is growing evidence that stellate ganglion block can contribute to decline patient morbidity from subarachnoid hemorrhage. Is it time to include this procedure as a standard treatment after aneurysm rupture?</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"21"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MGMT promoter methylation is a strong prognostic factor for survival after progression in high-grade gliomas. MGMT 启动子甲基化是影响高级别胶质瘤进展后生存的一个强有力的预后因素。
Q2 Medicine Pub Date : 2024-07-24 DOI: 10.1186/s41016-024-00375-2
Jing Zhang, Xiaoguang Qiu, Jin Feng, Yanwei Liu

Background: High-grade gliomas (HGGs) have a rapid relapse and short survival. Studies have identified many clinical characteristics and biomarkers associated with progression-free survival (PFS) and over-survival (OS). However, there has not yet a comprehensive study on survival after the first progression (SAP).

Methods: From CGGA and TCGA, 319 and 308 HGGs were confirmed as the first progression. The data on clinical characteristics and biomarkers were analyzed in accordance with OS, PFS, and SAP.

Results: Analysis of 319 patients from CGGA, significant predictors of improved OS/PFS/SAP were WHO grade, MGMT promoter methylation, and Ki-67 expression in univariate analysis. Further multivariate analysis showed MGMT promoter methylation and Ki-67 expression were independent predictors. However, an analysis of 308 patients from TCGA found MGMT promoter methylation is the only prognostic marker. A longer SAP was observed in patients with methylated MGMT promoter after standard chemoradiotherapy. In our data, HGGs could be divided into low, intermediate, and high-risk groups for SAP by MGMT methylation and Ki-67 expression.

Conclusions: Patients with MGMT promoter methylation have a prolonger SAP after standard chemoradiotherapy. HGGs could be divided into low, intermediate, and high-risk groups for SAP according to MGMT status and Ki-67 expression.

背景:高级别胶质瘤(HGGs)复发快、生存期短。研究发现了许多与无进展生存期(PFS)和超额生存期(OS)相关的临床特征和生物标志物。然而,目前还没有关于首次进展后生存期(SAP)的全面研究:方法:在 CGGA 和 TCGA 中,分别有 319 例和 308 例 HGG 被确认为首次进展。方法:从CGGA和TCGA中分别筛选出319例和308例HGG,根据OS、PFS和SAP分析临床特征和生物标志物数据:结果:对CGGA的319例患者进行分析发现,在单变量分析中,WHO分级、MGMT启动子甲基化和Ki-67表达是改善OS/PFS/SAP的重要预测因素。进一步的多变量分析显示,MGMT 启动子甲基化和 Ki-67 表达是独立的预测因素。然而,对 TCGA 中 308 例患者的分析发现,MGMT 启动子甲基化是唯一的预后标志物。在标准化放疗后,MGMT启动子甲基化的患者SAP较长。在我们的数据中,HGG可根据MGMT甲基化和Ki-67表达情况分为SAP的低、中、高风险组:结论:MGMT启动子甲基化患者在接受标准化放疗后SAP延长。根据MGMT状态和Ki-67表达情况,可将HGG分为SAP的低危、中危和高危组。
{"title":"MGMT promoter methylation is a strong prognostic factor for survival after progression in high-grade gliomas.","authors":"Jing Zhang, Xiaoguang Qiu, Jin Feng, Yanwei Liu","doi":"10.1186/s41016-024-00375-2","DOIUrl":"10.1186/s41016-024-00375-2","url":null,"abstract":"<p><strong>Background: </strong>High-grade gliomas (HGGs) have a rapid relapse and short survival. Studies have identified many clinical characteristics and biomarkers associated with progression-free survival (PFS) and over-survival (OS). However, there has not yet a comprehensive study on survival after the first progression (SAP).</p><p><strong>Methods: </strong>From CGGA and TCGA, 319 and 308 HGGs were confirmed as the first progression. The data on clinical characteristics and biomarkers were analyzed in accordance with OS, PFS, and SAP.</p><p><strong>Results: </strong>Analysis of 319 patients from CGGA, significant predictors of improved OS/PFS/SAP were WHO grade, MGMT promoter methylation, and Ki-67 expression in univariate analysis. Further multivariate analysis showed MGMT promoter methylation and Ki-67 expression were independent predictors. However, an analysis of 308 patients from TCGA found MGMT promoter methylation is the only prognostic marker. A longer SAP was observed in patients with methylated MGMT promoter after standard chemoradiotherapy. In our data, HGGs could be divided into low, intermediate, and high-risk groups for SAP by MGMT methylation and Ki-67 expression.</p><p><strong>Conclusions: </strong>Patients with MGMT promoter methylation have a prolonger SAP after standard chemoradiotherapy. HGGs could be divided into low, intermediate, and high-risk groups for SAP according to MGMT status and Ki-67 expression.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"24"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hybrid operation based on microsurgery assisted by intraoperative spinal angiography in patients with spinal dural arteriovenous fistula: a series of 45 cases from multicenter research. 脊髓硬膜动静脉瘘患者术中脊髓血管造影辅助显微外科混合手术:45 例多中心研究系列病例。
Q2 Medicine Pub Date : 2024-07-19 DOI: 10.1186/s41016-024-00372-5
Xiaorong Sun, Li Yu, Wenqing Jia, Wei Dai

Background: To assess the clinical effects of hybrid surgery, which includes spinal angiography-assisted microsurgery, in the treatment of spinal dural arteriovenous fistulas (SDAVF).

Methods: We retrospectively reviewed 45 patients who underwent hybrid Spinal dural arteriovenous fistula (SDAVF) resection between September 2019 and June 2022. The hybrid surgery involved intraoperative digital subtraction angiography (DSA) of the spinal vessels to determine the source of the blood-supplying artery, location of the fistula and draining vein, indocyanine green fluorescence (ICG)-assisted microsurgical resection of the fistula, and postoperative DSA to verify therapeutic efficacy. The Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Visual Analog Scale (VAS), Barthel score, modified Rankin Scale (mRS) and modified Aminoff-Logue score (key indicator) were used to assess the clinical effects of SDAVF resection.

Results: A series of 45 patients with SDAVF were successfully treated with hybrid surgery without fistula recurrence. There were no intraoperative complications related to spinal angiography, and none of the patients died. Postoperatively, two patients experienced clinical deterioration of spinal cord function, which manifested as bilateral lower extremity paralysis and bladder sphincter dysfunction. Postoperatively, improvement in mALS scores was observed in 16 cases (35.6%) within 1-2 days, 12 cases (26.7%) at 1 week, and 7 cases (15.6%) at 6 months. No SDAVF recurrence was detected in the spinal MRA examination 6 months after surgery. When compared with preoperative mALS scores, 35 cases (77.8%) showed significant improvement in symptoms, 8 cases (17.8%), remained unchanged, and 2 cases (4.4%) deteriorated. Compared with the preoperative scores, the postoperative mALS score was significantly decreased [postoperative vs. preoperative: 2(1,3) vs. 3(2,4)], HAMD score [(12.2 ± 5.5) vs. (19.6 ± 6.3)], HAMA score [(15.6 ± 5.5) vs. (20.5 ± 6.5)], and VAS score [3(2,5) vs. 5(4,8)]. Conversely, Barthel scoresshowed significant increase [(74.6 ± 8.7) vs. (67.8 ± 9.2)] (P < 0.05). However, the mRS scores were lower than preoperatively [1(1,2) vs. 2(1,2.5)], but the difference was not statistically significant (P > 0.05). There was a significant increase in "good" neurological outcomes at follow-up compared with preoperative function (62.2% vs. 33.3%) (P = 0.023).

Conclusion: Hybrid surgery is a safe and effective treatment for patients with SAVF, which is beneficial for improving anxiety, depression, spinal cord, and neurological function, and relieving pain. However, the treatment of patients with SDAVF is a complex, long-term process requiring further multidisciplinary interventions, including clinical care, psychosocial interventions, and neurorehabilitation.

背景:评估混合手术(包括脊柱血管造影辅助显微手术)治疗脊髓硬脑膜动静脉瘘(SDAVF)的临床效果:目的:评估混合手术(包括脊髓血管造影辅助显微手术)在治疗脊髓硬膜动静脉瘘(SDAVF)中的临床效果:我们对2019年9月至2022年6月期间接受混合脊髓硬膜动静脉瘘(SDAVF)切除术的45例患者进行了回顾性研究。混合手术包括术中脊髓血管数字减影血管造影(DSA)以确定供血动脉的来源、瘘管和引流静脉的位置、吲哚青绿荧光(ICG)辅助显微外科切除瘘管,以及术后DSA以验证疗效。汉密尔顿焦虑量表(HAMA)、汉密尔顿抑郁量表(HAMD)、视觉模拟量表(VAS)、Barthel评分、改良Rankin量表(mRS)和改良Aminoff-Logue评分(关键指标)用于评估SDAVF切除术的临床效果:结果:杂交手术成功治疗了45例SDAVF患者,且无瘘管复发。术中没有出现与脊髓血管造影相关的并发症,也没有患者死亡。术后,两名患者的脊髓功能出现临床恶化,表现为双下肢瘫痪和膀胱括约肌功能障碍。术后,16 例(35.6%)患者的 mALS 评分在 1-2 天内有所改善,12 例(26.7%)在 1 周内有所改善,7 例(15.6%)在 6 个月内有所改善。术后 6 个月的脊柱 MRA 检查未发现 SDAVF 复发。与术前的 mALS 评分相比,35 例(77.8%)患者的症状明显改善,8 例(17.8%)保持不变,2 例(4.4%)恶化。与术前评分相比,术后 mALS 评分明显下降[术后 vs. 术前:2(1,3) vs. 3(2,4)],HAMD 评分[(12.2 ± 5.5) vs. (19.6 ± 6.3)],HAMA 评分[(15.6 ± 5.5) vs. (20.5 ± 6.5)],VAS 评分[3(2,5) vs. 5(4,8)]。相反,巴特尔评分则显著增加[(74.6 ± 8.7) vs. (67.8 ± 9.2)](P 0.05)。与术前功能相比,随访时 "良好 "神经功能结果明显增加(62.2% 对 33.3%)(P = 0.023):混合手术是治疗 SAVF 患者的一种安全有效的方法,有利于改善焦虑、抑郁、脊髓和神经功能,缓解疼痛。然而,SDAVF 患者的治疗是一个复杂、长期的过程,需要进一步的多学科干预,包括临床护理、社会心理干预和神经康复。
{"title":"The hybrid operation based on microsurgery assisted by intraoperative spinal angiography in patients with spinal dural arteriovenous fistula: a series of 45 cases from multicenter research.","authors":"Xiaorong Sun, Li Yu, Wenqing Jia, Wei Dai","doi":"10.1186/s41016-024-00372-5","DOIUrl":"10.1186/s41016-024-00372-5","url":null,"abstract":"<p><strong>Background: </strong>To assess the clinical effects of hybrid surgery, which includes spinal angiography-assisted microsurgery, in the treatment of spinal dural arteriovenous fistulas (SDAVF).</p><p><strong>Methods: </strong>We retrospectively reviewed 45 patients who underwent hybrid Spinal dural arteriovenous fistula (SDAVF) resection between September 2019 and June 2022. The hybrid surgery involved intraoperative digital subtraction angiography (DSA) of the spinal vessels to determine the source of the blood-supplying artery, location of the fistula and draining vein, indocyanine green fluorescence (ICG)-assisted microsurgical resection of the fistula, and postoperative DSA to verify therapeutic efficacy. The Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Visual Analog Scale (VAS), Barthel score, modified Rankin Scale (mRS) and modified Aminoff-Logue score (key indicator) were used to assess the clinical effects of SDAVF resection.</p><p><strong>Results: </strong>A series of 45 patients with SDAVF were successfully treated with hybrid surgery without fistula recurrence. There were no intraoperative complications related to spinal angiography, and none of the patients died. Postoperatively, two patients experienced clinical deterioration of spinal cord function, which manifested as bilateral lower extremity paralysis and bladder sphincter dysfunction. Postoperatively, improvement in mALS scores was observed in 16 cases (35.6%) within 1-2 days, 12 cases (26.7%) at 1 week, and 7 cases (15.6%) at 6 months. No SDAVF recurrence was detected in the spinal MRA examination 6 months after surgery. When compared with preoperative mALS scores, 35 cases (77.8%) showed significant improvement in symptoms, 8 cases (17.8%), remained unchanged, and 2 cases (4.4%) deteriorated. Compared with the preoperative scores, the postoperative mALS score was significantly decreased [postoperative vs. preoperative: 2(1,3) vs. 3(2,4)], HAMD score [(12.2 ± 5.5) vs. (19.6 ± 6.3)], HAMA score [(15.6 ± 5.5) vs. (20.5 ± 6.5)], and VAS score [3(2,5) vs. 5(4,8)]. Conversely, Barthel scoresshowed significant increase [(74.6 ± 8.7) vs. (67.8 ± 9.2)] (P < 0.05). However, the mRS scores were lower than preoperatively [1(1,2) vs. 2(1,2.5)], but the difference was not statistically significant (P > 0.05). There was a significant increase in \"good\" neurological outcomes at follow-up compared with preoperative function (62.2% vs. 33.3%) (P = 0.023).</p><p><strong>Conclusion: </strong>Hybrid surgery is a safe and effective treatment for patients with SAVF, which is beneficial for improving anxiety, depression, spinal cord, and neurological function, and relieving pain. However, the treatment of patients with SDAVF is a complex, long-term process requiring further multidisciplinary interventions, including clinical care, psychosocial interventions, and neurorehabilitation.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"22"},"PeriodicalIF":0.0,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11264783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rivaroxaban's vascular dose for the neurovascular clinician. 神经血管临床医生的利伐沙班血管剂量。
Q2 Medicine Pub Date : 2024-07-03 DOI: 10.1186/s41016-024-00373-4
Ji Y Chong, Kalimullah Jan

Rivaroxaban, a direct oral anticoagulant, has proven efficacy and safety at its standard dose in the treatment and prevention of various vascular conditions. These include the treatment of venous thromboembolism and stroke prevention in non-valvular atrial fibrillation. A "very low" vascular dose of rivaroxaban, when combined with low-dose aspirin, has been demonstrated to reduce major adverse cardiovascular events, including stroke, in both acute and chronic coronary syndrome. The combination of rivaroxaban and low-dose aspirin could potentially offer an additional strategy for stroke prevention in selected non-atrial fibrillation patients who are at a high risk of stroke.

利伐沙班是一种直接口服抗凝剂,其标准剂量在治疗和预防各种血管疾病方面的疗效和安全性已得到证实。其中包括治疗静脉血栓栓塞和预防非瓣膜性心房颤动的中风。利伐沙班的 "极低 "血管剂量与低剂量阿司匹林联用,已被证实可减少急性和慢性冠状动脉综合征患者的主要不良心血管事件,包括中风。利伐沙班和低剂量阿司匹林的联合治疗有可能为特定的中风高风险非房颤患者提供预防中风的额外策略。
{"title":"Rivaroxaban's vascular dose for the neurovascular clinician.","authors":"Ji Y Chong, Kalimullah Jan","doi":"10.1186/s41016-024-00373-4","DOIUrl":"10.1186/s41016-024-00373-4","url":null,"abstract":"<p><p>Rivaroxaban, a direct oral anticoagulant, has proven efficacy and safety at its standard dose in the treatment and prevention of various vascular conditions. These include the treatment of venous thromboembolism and stroke prevention in non-valvular atrial fibrillation. A \"very low\" vascular dose of rivaroxaban, when combined with low-dose aspirin, has been demonstrated to reduce major adverse cardiovascular events, including stroke, in both acute and chronic coronary syndrome. The combination of rivaroxaban and low-dose aspirin could potentially offer an additional strategy for stroke prevention in selected non-atrial fibrillation patients who are at a high risk of stroke.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"20"},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knockdown of ATRX enhances radiosensitivity in glioblastoma. 敲除 ATRX 可增强胶质母细胞瘤的放射敏感性。
Q2 Medicine Pub Date : 2024-06-19 DOI: 10.1186/s41016-024-00371-6
Yue Zhao, Yifei Chen, Ruoyu Liu, Minghang Liu, Na You, Kai Zhao, Jiashu Zhang, Bainan Xu

Background: Glioblastoma are highly malignant type of primary brain tumors. Treatment for glioblastoma multiforme (GBM) generally involves surgery combined with chemotherapy and radiotherapy. However, the development of tumoral chemo- and radioresistance induces complexities in clinical practice. Multiple signaling pathways are known to be involved in radiation-induced cell survival. However, the role of alpha-thalassemia X-linked mutant retardation syndrome (ATRX), a chromatin remodeling protein, in GBM radioresistance remains unclear.

Methods: In the present study, the ATRX mutation rate in patients with glioma was obtained from The Cancer Genome Atlas, while its expression analyzed using bioinformatics. Datasets were also obtained from the Gene Expression Omnibus, and ATRX expression levels following irradiation of GBM were determined. The effects of ATRX on radiosensitivity were investigated using a knockdown assays.

Results: The present study demonstrated that the ATRX mutation rate in patients with GBM was significantly lower than that in patients with low-grade glioma, and that patients harboring an ATRX mutation exhibited a prolonged survival, compared with to those harboring the wild-type gene. Single-cell RNA sequencing demonstrated that ATRX counts increased 2 days after irradiation, with ATRX expression levels also increasing in U-251MG radioresistant cells. Moreover, the results of in vitro irradiation assays revealed that ATRX expression was increased in U-251MG cells, while ATRX knockdown was associated with increased levels of radiosensitivity.

Conclusions: High ATRX expression levels in primary GBM may contribute to high levels of radioresistance. Thus ATRX is a potential target for overcoming the radioresistance in GBM.

背景:胶质母细胞瘤是一种高度恶性的原发性脑肿瘤:胶质母细胞瘤是一种高度恶性的原发性脑肿瘤。多形性胶质母细胞瘤(GBM)的治疗通常包括手术、化疗和放疗。然而,肿瘤化疗和放疗耐药性的产生给临床实践带来了复杂性。已知有多种信号通路参与了辐射诱导的细胞存活。然而,染色质重塑蛋白阿尔法地中海贫血 X 连锁突变迟缓综合征(ATRX)在 GBM 抗放射中的作用仍不清楚:本研究从癌症基因组图谱(The Cancer Genome Atlas)中获取了胶质瘤患者的ATRX突变率,并使用生物信息学方法对其表达进行了分析。研究人员还从基因表达总库(Gene Expression Omnibus)中获取了数据集,并测定了胶质瘤照射后 ATRX 的表达水平。利用基因敲除实验研究了ATRX对放射敏感性的影响:本研究表明,GBM 患者的 ATRX 突变率明显低于低级别胶质瘤患者,与携带野生型基因的患者相比,携带 ATRX 突变的患者生存期更长。单细胞 RNA 测序表明,照射 2 天后,ATRX 数量增加,U-251MG 耐放射细胞中的 ATRX 表达水平也在增加。此外,体外辐照试验结果显示,U-251MG细胞中ATRX表达增加,而ATRX敲除与放射敏感性水平增加有关:结论:ATRX在原发性GBM中的高表达水平可能是导致高放射抗性的原因之一。因此,ATRX是克服GBM放射抗性的潜在靶点。
{"title":"Knockdown of ATRX enhances radiosensitivity in glioblastoma.","authors":"Yue Zhao, Yifei Chen, Ruoyu Liu, Minghang Liu, Na You, Kai Zhao, Jiashu Zhang, Bainan Xu","doi":"10.1186/s41016-024-00371-6","DOIUrl":"10.1186/s41016-024-00371-6","url":null,"abstract":"<p><strong>Background: </strong>Glioblastoma are highly malignant type of primary brain tumors. Treatment for glioblastoma multiforme (GBM) generally involves surgery combined with chemotherapy and radiotherapy. However, the development of tumoral chemo- and radioresistance induces complexities in clinical practice. Multiple signaling pathways are known to be involved in radiation-induced cell survival. However, the role of alpha-thalassemia X-linked mutant retardation syndrome (ATRX), a chromatin remodeling protein, in GBM radioresistance remains unclear.</p><p><strong>Methods: </strong>In the present study, the ATRX mutation rate in patients with glioma was obtained from The Cancer Genome Atlas, while its expression analyzed using bioinformatics. Datasets were also obtained from the Gene Expression Omnibus, and ATRX expression levels following irradiation of GBM were determined. The effects of ATRX on radiosensitivity were investigated using a knockdown assays.</p><p><strong>Results: </strong>The present study demonstrated that the ATRX mutation rate in patients with GBM was significantly lower than that in patients with low-grade glioma, and that patients harboring an ATRX mutation exhibited a prolonged survival, compared with to those harboring the wild-type gene. Single-cell RNA sequencing demonstrated that ATRX counts increased 2 days after irradiation, with ATRX expression levels also increasing in U-251MG radioresistant cells. Moreover, the results of in vitro irradiation assays revealed that ATRX expression was increased in U-251MG cells, while ATRX knockdown was associated with increased levels of radiosensitivity.</p><p><strong>Conclusions: </strong>High ATRX expression levels in primary GBM may contribute to high levels of radioresistance. Thus ATRX is a potential target for overcoming the radioresistance in GBM.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"19"},"PeriodicalIF":0.0,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11186225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141427819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics and treatment strategies for pituitary adenoma associated with intracranial aneurysm. 伴有颅内动脉瘤的垂体腺瘤的临床特征和治疗策略。
Q2 Medicine Pub Date : 2024-06-04 DOI: 10.1186/s41016-024-00370-7
Zheng Huang, Zeng Yang, Lixin Xu, Haibin Leng, Kui Yang, Wei Ding, Bo Xie, Fenghua Chen, Zhixiong Liu, Zhenyan Li

Background: This study aimed to investigate clinical features and treatment strategies for intracranial aneurysm (IA) associated with pituitary adenoma (PA).

Methods: We enrolled patients with lesions in the sellar region and age-matched general population who were confirmed with IA from two hospitals. Four types of treatment strategies were performed, which included Type I (both IA and PA were treated with surgery), Type II (IA was treated with surgery and PA was performed by non-surgical treatment), Type III (PA was performed with surgery and observation was available for IA) and Type IV (both IA and PA were performed with non-surgical treatment).

Results: The incidence of IA was 2.2% in the general population, 6.1% in patients with PA, 4.3% in patients with Rathke cleft cyst, 2.8% in patients with meningioma and none were found with IA in patients with craniopharyngioma. Age over 50 years (OR, 2.69; 95% CI, 1.20-6.04; P = 0.016), female (OR, 3.83, P = 0.003), and invasive tumor (OR, 3.26, P = 0.003) were associated with a higher incidence of IA in patients with PA. During the mean follow-up of 49.2 months, no patients experienced stroke, and recurrence of aneurysms and aneurysms treated with observation were stable. Of four patients with recurrence of PA, three patients were treated for type I and one patient for type III.

Conclusions: Preoperative evaluation for aneurysm screening is necessary due to the high incidence of IA in PA patients. Our current treatment strategies may provide a benefit for these patients.

背景:本研究旨在探讨垂体腺瘤(PA)相关颅内动脉瘤(IA)的临床特征和治疗策略:本研究旨在探讨与垂体腺瘤(PA)相关的颅内动脉瘤(IA)的临床特征和治疗策略:方法:我们从两家医院招募了颅内病变位于蝶鞍区的患者和年龄匹配的普通人群,这些患者均被确诊为颅内动脉瘤。结果:IA的发病率为2.2%,而PA的发病率为2.2%:一般人群中IA的发生率为2.2%,PA患者为6.1%,Rathke裂隙囊肿患者为4.3%,脑膜瘤患者为2.8%,颅咽管瘤患者中未发现IA。年龄超过 50 岁(OR,2.69;95% CI,1.20-6.04;P = 0.016)、女性(OR,3.83,P = 0.003)和浸润性肿瘤(OR,3.26,P = 0.003)与 PA 患者 IA 发生率较高有关。在平均 49.2 个月的随访期间,没有患者发生中风,动脉瘤复发和接受观察治疗的动脉瘤情况稳定。在四名PA复发患者中,三名患者接受了I型治疗,一名患者接受了III型治疗:结论:由于 PA 患者中 IA 的发病率较高,因此术前评估动脉瘤筛查很有必要。我们目前的治疗策略可能会使这些患者受益。
{"title":"Clinical characteristics and treatment strategies for pituitary adenoma associated with intracranial aneurysm.","authors":"Zheng Huang, Zeng Yang, Lixin Xu, Haibin Leng, Kui Yang, Wei Ding, Bo Xie, Fenghua Chen, Zhixiong Liu, Zhenyan Li","doi":"10.1186/s41016-024-00370-7","DOIUrl":"10.1186/s41016-024-00370-7","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate clinical features and treatment strategies for intracranial aneurysm (IA) associated with pituitary adenoma (PA).</p><p><strong>Methods: </strong>We enrolled patients with lesions in the sellar region and age-matched general population who were confirmed with IA from two hospitals. Four types of treatment strategies were performed, which included Type I (both IA and PA were treated with surgery), Type II (IA was treated with surgery and PA was performed by non-surgical treatment), Type III (PA was performed with surgery and observation was available for IA) and Type IV (both IA and PA were performed with non-surgical treatment).</p><p><strong>Results: </strong>The incidence of IA was 2.2% in the general population, 6.1% in patients with PA, 4.3% in patients with Rathke cleft cyst, 2.8% in patients with meningioma and none were found with IA in patients with craniopharyngioma. Age over 50 years (OR, 2.69; 95% CI, 1.20-6.04; P = 0.016), female (OR, 3.83, P = 0.003), and invasive tumor (OR, 3.26, P = 0.003) were associated with a higher incidence of IA in patients with PA. During the mean follow-up of 49.2 months, no patients experienced stroke, and recurrence of aneurysms and aneurysms treated with observation were stable. Of four patients with recurrence of PA, three patients were treated for type I and one patient for type III.</p><p><strong>Conclusions: </strong>Preoperative evaluation for aneurysm screening is necessary due to the high incidence of IA in PA patients. Our current treatment strategies may provide a benefit for these patients.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"10 1","pages":"18"},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11149326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141248931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Neurosurgical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1